These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 35656882)

  • 1. Overexpression of ERCC6L correlates with poor prognosis and confers malignant phenotypes of lung adenocarcinoma.
    Huang X; Jiang L; Lu S; Yuan M; Lin H; Li B; Wen Z; Zhong Y
    Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35656882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma.
    Hou G; Lu Z; Bi Y; Deng J; Yang X
    Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
    Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
    BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic role of abnormal spindle‑like microcephaly‑associated protein in lung adenocarcinoma.
    Wang J; Liang J; Li H; Han J; Jiang J; Li Y; Feng Z; Zhao R; Tian H
    Int J Oncol; 2021 May; 58(5):. PubMed ID: 33786609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RFC3 induces epithelial‑mesenchymal transition in lung adenocarcinoma cells through the Wnt/β‑catenin pathway and possesses prognostic value in lung adenocarcinoma.
    Gong S; Qu X; Yang S; Zhou S; Li P; Zhang Q
    Int J Mol Med; 2019 Dec; 44(6):2276-2288. PubMed ID: 31661124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ERCC6L promotes the progression of hepatocellular carcinoma through activating PI3K/AKT and NF-κB signaling pathway.
    Chen H; Wang H; Yu X; Zhou S; Zhang Y; Wang Z; Huang S; Wang Z
    BMC Cancer; 2020 Sep; 20(1):853. PubMed ID: 32891122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 9. Overexpression of KIF18A promotes cell proliferation, inhibits apoptosis, and independently predicts unfavorable prognosis in lung adenocarcinoma.
    Zhong Y; Jiang L; Lin H; Li X; Long X; Zhou Y; Li B; Li Z
    IUBMB Life; 2019 Jul; 71(7):942-955. PubMed ID: 30817091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC6L, a DNA helicase, is involved in cell proliferation and associated with survival and progress in breast and kidney cancers.
    Pu SY; Yu Q; Wu H; Jiang JJ; Chen XQ; He YH; Kong QP
    Oncotarget; 2017 Jun; 8(26):42116-42124. PubMed ID: 28178669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of Excision Repair Cross-Complementation Group 6-Like (ERCC6L) Promotes Tumor Growth in Hepatocellular Carcinoma.
    Zhang G; Ma J; Xiong J; Huang X; Han X; Yu X; Jiang X
    Dig Dis Sci; 2021 Apr; 66(4):1097-1109. PubMed ID: 32347436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. shRNA knockdown of DNA helicase ERCC6L expression inhibits human breast cancer growth.
    Liu J; Sun J; Zhang Q; Zeng Z
    Mol Med Rep; 2018 Sep; 18(3):3490-3496. PubMed ID: 30066865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KIAA1429 promotes the progression of lung adenocarcinoma by regulating the m6A level of MUC3A.
    Zhao W; Xie Y
    Pathol Res Pract; 2021 Jan; 217():153284. PubMed ID: 33249400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin A knockdown decreases the proliferation and invasion of A549 lung adenocarcinoma cells.
    Hu B; Zhu X; Lu J
    Mol Med Rep; 2020 Jun; 21(6):2553-2559. PubMed ID: 32323791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIF-1ɑ-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt/β-catenin and Notch signaling.
    Jiang N; Zou C; Zhu Y; Luo Y; Chen L; Lei Y; Tang K; Sun Y; Zhang W; Li S; He Q; Zhou J; Chen Y; Luo J; Jiang W; Ke Z
    Theranostics; 2020; 10(6):2553-2570. PubMed ID: 32194819
    [No Abstract]   [Full Text] [Related]  

  • 17. High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma.
    Jin CY; Du L; Nuerlan AH; Wang XL; Yang YW; Guo R
    Aging (Albany NY); 2020 Dec; 13(3):3518-3535. PubMed ID: 33411689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmacytoma variant translocation 1 stabilized by EIF4A3 promoted malignant biological behaviors of lung adenocarcinoma by generating circular RNA LMNB2.
    Qiu M; Chen M; Lan Z; Liu B; Xie J; Li X
    Bioengineered; 2022 Apr; 13(4):10123-10140. PubMed ID: 35435126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAFAH1B3 predicts poor prognosis and promotes progression in lung adenocarcinoma.
    Tang S; Ni J; Chen B; Sun F; Huang J; Ni S; Tang Z
    BMC Cancer; 2022 May; 22(1):525. PubMed ID: 35534807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ITGB4 as a novel tumor promoting gene in lung adenocarcinoma (LUAD).
    Lu X; Ma S; Li Y; Pan Y; Kang N
    Oncol Rep; 2024 Feb; 51(2):. PubMed ID: 38131229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.